Clinical Trials Browser

Phase EARLY_PHASE1 × Neuroblastoma × naxitamab × Clear all

NCT03189706 2025-07-02

Study of Chemoimmunotherapy for High-Risk Neuroblastoma

Phase EARLY_PHASE1 Active not recruiting

Neuroblastoma